Covishield produces more antibodies with higher seropositivity rate than Covaxin: Preliminary study

A preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) has stated Covishield vaccine produced more antibodies than Covaxin. The study, involving healthcare workers (HCW) who have received both doses of either of the two vaccines, also said seropositivity rates to anti-spike antibody were significantly higher in Covishield recipients as compared to Covaxin after the first dose.

A preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) has stated Covishield vaccine produced more antibodies than Covaxin. The study, involving healthcare workers (HCW) who have received both doses of either of the two vaccines, also said seropositivity rates to anti-spike antibody were significantly higher in Covishield recipients as compared to Covaxin after the first dose. June 07, 2021 at 08:41AM https://ift.tt/3vYPE7o